KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Change in Acquisitions & Divestments (2017 - 2025)

Twist Bioscience (TWST) has disclosed Change in Acquisitions & Divestments for 7 consecutive years, with $18.2 million as the latest value for Q3 2023.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 27.06% to $18.2 million in Q3 2023 year-over-year; TTM through Sep 2023 was $154.7 million, a 54.0% increase, with the full-year FY2025 number at $50.1 million, down 7.0% from a year prior.
  • Change in Acquisitions & Divestments was $18.2 million for Q3 2023 at Twist Bioscience, down from $31.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $112.0 million in Q2 2021 to a low of $12.0 million in Q4 2021.
  • A 5-year average of $39.5 million and a median of $32.0 million in 2020 define the central range for Change in Acquisitions & Divestments.
  • Peak YoY movement for Change in Acquisitions & Divestments: surged 2587.5% in 2019, then crashed 71.91% in 2022.
  • Twist Bioscience's Change in Acquisitions & Divestments stood at $21.0 million in 2019, then skyrocketed by 52.38% to $32.0 million in 2020, then tumbled by 62.5% to $12.0 million in 2021, then surged by 129.17% to $27.5 million in 2022, then tumbled by 33.69% to $18.2 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Change in Acquisitions & Divestments are $18.2 million (Q3 2023), $31.0 million (Q2 2023), and $78.0 million (Q1 2023).